RedHill Biopharma (RDHL) Shares Issued (2012 - 2013)
RedHill Biopharma's (RDHL) quarterly Shares Issued came in at $43.1 million in Q4 2013, up 37.1% year-on-year from $31.5 million in Q4 2012, and up 174.3% on a QoQ basis from $15.7 million in Q1 2013.
RedHill Biopharma (RDHL) Shares Issued (2012 - 2013) Analysis & Trends
RedHill Biopharma (RDHL) has 2 years of Shares Issued data on file, last reported at $43.1 million in Q4 2013.
- On a quarterly basis, Shares Issued rose 37.1% year-over-year to $43.1 million in Q4 2013; TTM through Dec 2013 was $43.1 million, a 37.1% increase from a year earlier, with the FY2013 full-year figure at $43.1 million, up 37.1% from the prior year.
- Shares Issued for Q4 2013 stood at $43.1 million, up from $15.7 million in the prior quarter.
- Over the last five years, Shares Issued for RDHL reached as high as $43.1 million in Q4 2013 and fell as low as $6.7 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 43.14 Mn |
| Dec 31, 2013 | 43.14 Mn |
| Mar 31, 2013 | 15.73 Mn |
| Mar 31, 2013 | 15.73 Mn |
| Dec 31, 2012 | 31.47 Mn |
| Dec 31, 2012 | 31.47 Mn |
| Mar 31, 2012 | 6.69 Mn |
| Mar 31, 2012 | 6.69 Mn |